Cargando…

The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature

BACKGROUND: Antenatally diagnosed sacrococcygeal teratoma has been associated with risks of perinatal complications and death, especially when the foetus has symptoms of cardiac insufficiency, hydrops or anemia in utero; however, the method of intervention remains controversial. CASE: A 25-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yunping, Yang, Mengmeng, Lv, Min, Jiang, Ying, Dong, Tian, Zhao, Baihui, Luo, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666771/
https://www.ncbi.nlm.nih.gov/pubmed/36408142
http://dx.doi.org/10.3389/fonc.2022.1035058
_version_ 1784831583646121984
author Ding, Yunping
Yang, Mengmeng
Lv, Min
Jiang, Ying
Dong, Tian
Zhao, Baihui
Luo, Qiong
author_facet Ding, Yunping
Yang, Mengmeng
Lv, Min
Jiang, Ying
Dong, Tian
Zhao, Baihui
Luo, Qiong
author_sort Ding, Yunping
collection PubMed
description BACKGROUND: Antenatally diagnosed sacrococcygeal teratoma has been associated with risks of perinatal complications and death, especially when the foetus has symptoms of cardiac insufficiency, hydrops or anemia in utero; however, the method of intervention remains controversial. CASE: A 25-year-old pregnant woman was found to have a cystic and solid tumor in the fetal sacrococcygeal region at 16 weeks of gestation. As the tumour grew, the mother developed polyhydramnios accompanied with gestational diabetes. Fetal and tumorous hemodynamics were closely monitored by ultrasound. Abnormal cardiac function was detected at 31 weeks’ gestation, and we creatively performed pre-emptive delivery through the ex-utero intrapartum treatment with debulking. The teratoma was removed with utero-placental circulation support. The operation proceeded smoothly with favourable prognosis for both mother and newborn. CONCLUSION: The ex-utero intrapartum treatment may improve the prognosis for fetuses with heart failure when they reach viable gestation.
format Online
Article
Text
id pubmed-9666771
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96667712022-11-17 The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature Ding, Yunping Yang, Mengmeng Lv, Min Jiang, Ying Dong, Tian Zhao, Baihui Luo, Qiong Front Oncol Oncology BACKGROUND: Antenatally diagnosed sacrococcygeal teratoma has been associated with risks of perinatal complications and death, especially when the foetus has symptoms of cardiac insufficiency, hydrops or anemia in utero; however, the method of intervention remains controversial. CASE: A 25-year-old pregnant woman was found to have a cystic and solid tumor in the fetal sacrococcygeal region at 16 weeks of gestation. As the tumour grew, the mother developed polyhydramnios accompanied with gestational diabetes. Fetal and tumorous hemodynamics were closely monitored by ultrasound. Abnormal cardiac function was detected at 31 weeks’ gestation, and we creatively performed pre-emptive delivery through the ex-utero intrapartum treatment with debulking. The teratoma was removed with utero-placental circulation support. The operation proceeded smoothly with favourable prognosis for both mother and newborn. CONCLUSION: The ex-utero intrapartum treatment may improve the prognosis for fetuses with heart failure when they reach viable gestation. Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9666771/ /pubmed/36408142 http://dx.doi.org/10.3389/fonc.2022.1035058 Text en Copyright © 2022 Ding, Yang, Lv, Jiang, Dong, Zhao and Luo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ding, Yunping
Yang, Mengmeng
Lv, Min
Jiang, Ying
Dong, Tian
Zhao, Baihui
Luo, Qiong
The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
title The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
title_full The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
title_fullStr The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
title_full_unstemmed The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
title_short The ex-utero intrapartum treatment (EXIT) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: A case report and review of the literature
title_sort ex-utero intrapartum treatment (exit) strategy for fetal giant sacrococcygeal teratoma with cardiac insufficiency: a case report and review of the literature
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666771/
https://www.ncbi.nlm.nih.gov/pubmed/36408142
http://dx.doi.org/10.3389/fonc.2022.1035058
work_keys_str_mv AT dingyunping theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT yangmengmeng theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT lvmin theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT jiangying theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT dongtian theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT zhaobaihui theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT luoqiong theexuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT dingyunping exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT yangmengmeng exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT lvmin exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT jiangying exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT dongtian exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT zhaobaihui exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature
AT luoqiong exuterointrapartumtreatmentexitstrategyforfetalgiantsacrococcygealteratomawithcardiacinsufficiencyacasereportandreviewoftheliterature